CN3- COST-EFFECTIVENESS ANALYSIS OF IRINOTECAN5FU/FA ALONE AS FIRST-LINE THERAPY IN ADVANCED COLORECTAL CANCER IN THE UK
Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40201-19.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71130-5/fulltext
Title :
CN3- COST-EFFECTIVENESS ANALYSIS OF IRINOTECAN5FU/FA ALONE AS FIRST-LINE THERAPY IN ADVANCED COLORECTAL CANCER IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71130-5&doi=10.1046/j.1524-4733.2001.40201-19.x
First page :
Section Title :
Open access? :
No
Section Order :
19